Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib O.F. Olmez, A. Bilici, P. Gursoy, E. Cubukcu, A. Sakin, T. Korkmaz, I. Cil, B. Cakar, S. Menekse, T. Demir, O. Acikgoz, J. Hamdard

Lung cancer in pregnancy – Report of a case treated with crizotinib E. Padrão, C. Melo, G. Fernandes, A. Magalhães

Inflammatory prognostic biomarkers in advanced non-small cell lung cancer D. Machado, C. Marques, M. Dias, S. Campainha, A. Barroso